Spirodiketopiperazine-based CCR5 antagonists: Lead optimization from biologically active metabolite. (Q51802017)
Jump to navigation
Jump to search
scientific article published in November 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Spirodiketopiperazine-based CCR5 antagonists: Lead optimization from biologically active metabolite. |
scientific article published in November 2006 |
Statements
Spirodiketopiperazine-based CCR5 antagonists: Lead optimization from biologically active metabolite (English)
Rena Nishizawa
Toshihiko Nishiyama
Katsuya Hisaichi
Naoki Matsunaga
Chiaki Minamoto
Hiromu Habashita
Yoshikazu Takaoka
Masaaki Toda
Shiro Shibayama
Hideaki Tada
Kenji Sagawa
Daikichi Fukushima
Hiroaki Mitsuya
1 November 2006